Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Blood Advances
|
May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis
Barbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Blood Advances
|
August 30, 2021
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
Howard Lin, Brooks P Scull, Baruch R Goldberg, et al.
Cancer
|
April 30, 2024
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Blood Advances
|
May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis
Barbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Blood Advances
|
August 30, 2021
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
Howard Lin, Brooks P Scull, Baruch R Goldberg, et al.
Cancer
|
April 30, 2024
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, et al.
Page
of 5